Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex
Juan-Juan Yin,1,2 Stepan P Shumyak,2 Christopher Burgess,2 Zhi-Wei Zhou,2 Zhi-Xu He,3 Xue-Ji Zhang,4 Shu-Ting Pan,2,5 Tian-Xin Yang,6 Wei Duan,7 Jia-Xuan Qiu,5 Shu-Feng Zhou21Xiaolan People’s Hospital, Southern Medical University, Zhongshan, Guangdong, People’s Republic of China;...
Guardado en:
Autores principales: | Yin JJ, Shumyak SP, Burgess C, Zhou ZW, He ZX, Zhang XJ, Pan ST, Yang T, Duan W, Qiu JX, Zhou SF |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d35d04bebd564dab83d8f58d81183a62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Estrogen-induced nongenomic calcium signaling inhibits lipopolysaccharide-stimulated tumor necrosis factor α production in macrophages.
por: Limin Liu, et al.
Publicado: (2013) -
Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
por: Juan-Juan Yin, et al.
Publicado: (2013) -
Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application
por: Song W, et al.
Publicado: (2011) -
Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα
por: Liqun Chen, et al.
Publicado: (2017) -
Construction and application of a liver cancer-targeting drug delivery system based on core–shell gold nanocages
por: Ji MF, et al.
Publicado: (2018)